A Prospective, Multicenter, Randomized, Parallel-Arm, Bilateral, Double-Masked, Vehicle Controlled Feasibility Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Dry Eye

Trial Profile

A Prospective, Multicenter, Randomized, Parallel-Arm, Bilateral, Double-Masked, Vehicle Controlled Feasibility Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Dry Eye

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Dec 2016

At a glance

  • Drugs Dexamethasone (Primary)
  • Indications Dry eyes
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Aug 2016 Status changed from active, no longer recruiting to completed, according to Ocular Therapeutix media release.
    • 10 Mar 2016 Primary endpoint (Corneal Fluorescein Staining and Conjunctival Lissamine Green Staining using the NEI Scale) has been met, according to an Ocular Therapeutix media release.
    • 10 Feb 2016 Planned End Date changed from 1 Dec 2015 to 1 Apr 2016, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top